PITUITARY STALK INTERRUPTION SYNDROME

This adverse event was reported 15 times

These drugs are most commonly taken by patients reporting PITUITARY STALK INTERRUPTION SYNDROME:

# Drug Count
0 DUPILUMAB 11
1 FLUTICASONE FUROATE 11
2 MIRTAZAPINE 11
3 OMALIZUMAB 11
4 PREDNISONE 11
5 0XYGEN 7
6 OXYGEN 7
7 CABERGOLINE 2
8 PASIREOTIDE 2
9 PEGVISOMANT 2
See all common drugs associated with PITUITARY STALK INTERRUPTION SYNDROME

PITUITARY STALK INTERRUPTION SYNDROME is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PASIREOTIDE 2 0.0009
1 SOMATROGON-GHLA 1 0.0008
2 PEGVISOMANT 2 0.0005
3 CABERGOLINE 2 0.0004
4 0XYGEN 7 0.0001
5 OXYGEN 7 0.0001
6 OMALIZUMAB 11 0.0001
7 MIRTAZAPINE 11 0.0001
8 TAPENTADOL HYDROCHLORIDE 1 0.0000
9 PREDNISONE 11 0.0000
See all drugs enriched for association with PITUITARY STALK INTERRUPTION SYNDROME

PITUITARY STALK INTERRUPTION SYNDROME is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Ergot Derivative [EPC] 2 0.0004
1 Somatostatin Analog [EPC] 2 0.0003
2 Anti-IgE [EPC] 11 0.0001
3 Interleukin-4 Receptor alpha Antagonist [EPC] 11 0.0000
4 Corticosteroid [EPC] 11 0.0000
5 Opioid Agonist [EPC] 1 0.0000
6 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000
See all drug classes enriched for association with PITUITARY STALK INTERRUPTION SYNDROME